Tailoring dual antiplatelet therapy for stroke prevention: a meta-analysis of timing, duration, regimen, and stroke subtypes.

Front Pharmacol · 2025 · PMC12058503 · PMID 40343004

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

While aspirin plus cilostazol showed a trend towards reducing stroke risk, this was not statistically significant (RR 0.52, 95% CI 0.19–1.39).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.